V
Visus Therapeutics
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Org chart
Ben Bergo
CEO
Collapse
Rhett Schiffman
Chief Medical Officer & Head of R&D
David Toll
CFO
Lisa Simpson
VP, Clinical Operations & Compliance
Andy Firpo
VP, Information Technology
Esther Cuno
VP, Human Resources
Board & advisors
David Guyer
Chairman
John de Koning
Director
Sam Lanyon
Director
Dwight Moxie
Director
Tracy M. Valorie
Director
Eric Donnenfeld
Advisor
Herb Kaufman
Advisor
Jim Mazzo
Advisor
Tomi Sawyer
Advisor